Scholars
| Title | Link |
|---|---|
| Kurt R. Karst - Comments Pediatric Testing of Prescription Drugs: the Food and Drug Administration's Carrot and Stick for the Pharmaceutical Industry - American University Law Review Vol. 49:739 - 2000 - (34 pages) | http://www.wcl.american.edu/journal/lawrev/49/karst.pdf |
| Jean-Louis Duc, Professeur UNIL - Quelques réflexions en rapport avec la dispensation des médicaments à la lumière de l'exemple vaudois - (21 pages) | http://www.unil.ch/droit/publ_jld/Medicaments.pdf |
| IHGT -Insitute for Human Gene Therapy - University of Pennsylvania - More information on OTC Deficiency and the Clinical Trial | http://www.uphs.upenn.edu/ihgt/otcinfo.html |
| Association of American Medical Colleges - Protecting Subjects, Preserving Trust, Promoting Progress– Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research - December 2001 - (25 pages) | http://www.aamc.org/members/coitf/firstreport.pdf |
| Report of Independent Panel Reviewing the University of Pennsylvania's Institute for Human Gene Therapy | http://www.upenn.edu/almanac/v46/n34/IHGT-review.html |
| Action by the University of Pennsylvania in Response to the "Report of the Independent Panel Reviewing the Institute for Human Gene Therapy" | http://www.upenn.edu/almanac/v46/n34/OR-IHGT-actions.html |
| University of Pennsylvania - ORA web site home page - regulatory affairs | http://www.upenn.edu/regulatoryaffairs/ |
| Lawrence M. Sung - Echoes of Scientific Truth in the Halls of Justice: The Standards of Review Applied by the United States Court of Appears for the Federal Circuit in Patent-Realted Matters - 1999 - American University Law Review - (86 pages) | http://www.wcl.american.edu/journal/lawrev/48/pdf/sung.pdf |
| Anna E. Morrison - The U.S. PTO's New Utility Guidelines: Will They Be Enough to Secure Gene Patent Rights? - 1 J. MARSHALL REV. INTELL. PROP. L. 142 - 2001 - (22 pages) | http://www.jmls.edu/ripl/vol1/issue1/morrison.pdf |
| Lawrence M. Sung - Part II: Judicial Issues Stranger In A Strange Land: Biotechnology and the Federal Circuit - 168 Re-Engineering Patent Law Vol. 2:167- (32 pages) | http://law.wustl.edu/Journal/2/p167sung.pdf |
| Sherry M. Knowles - Written Description and Enablement Requirements for Pharmaceutical, Chemical and Biotechnology Inventions - (36 pages) | http://www.kslaw.com/library/pdf/pharmaknowles.pdf |
| Matthew D. Kellam - Making Sense out of Antisense: The Enablement Requirement in Biotechnology After Enzo Biochem v. Calgene - 222 INDIANA LAW JOURNAL [Vol. 76:221 - (22 pages) | http://www.law.indiana.edu/ilj/v76/no1/kellam.pdf |
| Arti Kaur Rai - Regulating Scientific Research: Intellectual Property Rights and the Norms of Science - Nortwestern University Law Review - 1999 - (76 pages) | http://www.acusd.edu/~arai/raifinal.pdf |
| Mattias Ganslandt and Keith E. Maskus - Parallel Imports of Pharmaceutical Products in the European Union - Please do not quote without permission - (27 pages) | http://econ.worldbank.org/files/2240_wps2630.pdf |
| Mattias Ganslandt and Keith E. Maskus - Parallel Imports of Pharmaceutical Products in the European Union - The Research Institute of Industrial Economics - Working Paper No. 546, 2001 - (28 pages) | http://swopec.hhs.se/iuiwop/papers/iuiwop0546.pdf |
| François Dessemontet - L’épuisement en droit des brevets : un arrêt de principe - CEDIDAC Bulletin d’information n° 32 – Décembre 1999 - (9 pages) | http://www.unil.ch/cedidac/bulletin/bulletin_32.pdf |
| H. Peter Steeves - “Start a Line and Get Me a Consent Waiver, STAT!” Autonomy, Community Consultation, and Informed Consent in Emergency Research - (54 pages) | http://www.ars-rhetorica.net/Queen/VolumeSpecialIssue/Articles/Steeves.pdf |
| Lausanne University - Règlement de la Commission Permanente d'Ethique de la Recherche Clinique - (6 pages) | http://www.unil.ch/cercfm/docs/Regl_cercfm_2000.pdf |
| Lausanne University - Recommandations pour la rédaction d'un protocole de recherche soumis à la Commission d'Ethique de la Recherche clinique de la Faculté de Médecine | http://www.unil.ch/cercfm/recommandations.html |
| Lausanne University - Exemple de formulaire de consentement éclairé (consentement écrit) | http://www.unil.ch/cercfm/formulaire.html |
| Lausanne University - Demande d’évaluation de l’essai clinique: | http://www.unil.ch/cercfm/docs/SoumissionLS.dot.pdf |
| Geneva University - Conclusions et mesures du rectorat faisant suite à la dénonciation sur l’existence de liens entre l’industrie du tabac et l’Université de Genève - November 6, 2001 | http://www.prevention.ch/ryrapuni061101.htm |
| Rika Onishi Mortimer - Demand for Prescription Drugs: The Effects of Managed Care Pharmacy Benefits - (57 pages) | http://econwpa.wustl.edu:8089/eps/hew/papers/9802/9802002.pdf |
| Anna Merino-Castelló - The impact of the reference price system on the pharmaceutical market: a theoretical approach- February, 2000 - (32 pages) | http://www.econ.upf.es/deehome/what/wpapers/postscripts/524.pdf |
| Gray, Sidney Skogsvik, Kenth - The Valuation Relevance of Voluntary Disclosures: A Comparative Analysis of the Disclosure Behaviour of Major Pharmaceutical Companies in Sweden and the UK - (25 pag | http://www.econ.upf.es/deehome/what/wpapers/postscripts/524.pdf |
| Gregory S. Crawford and Matthew Shum - Uncertainty and Learning in Pharmaceutical Demand - February 2000 - (42 pages) | ftp://ftp.econ.duke.edu/pub/gsc/match.pdf |
| Gregory Crawford Matthew Shum - State Dependence in Pharmaceutical Prescription Choice: Implications for Physician Authority and Market Structure - 1998 - (19 pages) | ftp://ftp.econ.duke.edu/pub/gsc/habit.pdf |
| Elli Malki - Intellectual property and the valuation of biotechnology companies: GEN-dex versus Dow Jones - (11 pages) | http://econwpa.wustl.edu:8089/eps/fin/papers/9709/9709002.pdf |
| Andreas Pyka and Paolo Saviotti - Innovation Networks in the Biotechnology-Based Sectors - July 2001 - (35 pages) | http://www.wiwi.uni-augsburg.de/vwl/institut/paper/205.pdf |
| Thomas Aronsson Mats A. Bergman and Niklas Rudholm - The Impact of Generic Competition on Brand Name Market Shares: Evidence from Micro Data- December 1997 - (22 pages) | http://swopec.hhs.se/hastef/papers/hastef0274.pdf |
| Guillem López-Casasnovas Jaume Puig-Junoy - Review of the Literature on Reference Pricing - April 14th, 2000 - (47 pages) | http://www.econ.upf.es/deehome/what/wpapers/postscripts/362.pdf |
| James G. Silva - Copyright Protection Of Biotechnology Works: Into The Dustbin Of History? - 2000 B.C. Intell. Prop. & Tech. F. 012801 - January 28, 2000 | http://infoeagle.bc.edu/bc_org/avp/law/st_org/iptf/articles/content/2000012801.html |
| Stanford University - Sample Consent Form for informed consent to participate in a clinical trial (9 pages) | http://humansubjects.stanford.edu/medical/SUSampCons.html |
| Mark P. Mobach & Jos J. van der Werf & T.(Dick) F.J. Tromp - APOM-project: an investigation of pharmacy organization and management - (22 pages) | http://www.ub.rug.nl/eldoc/som/97A07/97a07.pdf |
| Léo-Paul Lauzon & Marc Hasbani - Analyse socio-économique de l'industrie pharmaceutique brevetée pour la période de dix ans (1991-2000) - Avril 2002 | http://www.unites.uqam.ca/cese/etude24pharm/pharmtab.html |
| Frank P. Porcelli - John A. Dragseth - Patents A Historical Perspective - Ver. 2002 - (610 pages) | http://www.law.upenn.edu/patents/sp2002/downloads/2002_casebook.pdf |
| Notes from class of Professor Wagner at the University of Pennsylvania Law School | http://www.law.upenn.edu/patents/sp2002/ |
| Todd Mattingly Paul Morico Linda Stokley and Janelle Waack - Recent Developments in Patent Law - (16 pages) | http://www.utexas.edu/law/journals/tiplj/volumes/vol4iss3/stokley.pdf |
| Harvard Bioethics discussion group - Program on Ethical Issues in International Health Research at the Harvard School of Public Health - E-mail list | http://www.hsph.harvard.edu/bioethics/ |
| Gianfranco Domenighetti , Jenny Maggi - Définition des priorités sanitaires et rationnement - L’opinion des Suisses, des Administrateurs hospitaliers et des Départements sanitaires des Cantons - Janvier 2000 | http://www.hec.unil.ch/Deep/Textes/00.01.pdf |
| Gianfranco Domenighetti - I consumatori scientificamente informati - (8 pages) | http://www.ti.ch/DOS/DSP/SezS/pdf/Salute_e_territorio_1999%20112-113%20GD.pdf |
| Gianfranco Domenighetti - Position Paper - Informed Choice in Screening - (10 pages) | http://www.ti.ch/DOS/DSP/SezS/pdf/Sezione_Sanitaria_GD_2001.pdf |
| G. Domenighetti , B. D'Avanzo , B. Bisig - Health Effects of Job Insecurity Among Employees in Swiss General Population - April 1999 - (18 pages) | http://www.ti.ch/DOS/DSP/SezS/pdf/Sezione_Sanitaria_GD_2001.pdf |
| Holly Aprea - FDA Regulation of Tobacco A Closer Look at the Forces Contributing to the Movement for Regulation - 2001 - (118 pages) | http://www.american.edu/academic.depts/honors/CurrentStudents/capstones/aprea.pdf |
| Richard Cookson - The Role of Industry in Evaluation of Health Interventions - (20 pages) | http://www.lse.ac.uk/Depts/lsehsc/pdf_files/industry.pdf |
| Julian Le Grand. - The Provision of Health Care: Is The Public Sector Ethically Superior To The Private Sector? (21 pages) | http://www.lse.ac.uk/Depts/lsehsc/pdf_files/DP1.pdf |
| Adam Oliver - The End of The Beginning: Eliciting Cardinal Values For Health States - (26 pages) | http://www.lse.ac.uk/Depts/lsehsc/pdf_files/dp2oliver.pdf |
| Chrisanthi Avgerou, Tony Cornford and Elias Mossialos - Drug Use Information Systems: A European Perspective, August 1995.- (26 pages) | http://www.lse.ac.uk/Depts/lsehsc/papers/Discussion_Papers/dp2.pdf |
| List of LSE publications on healthcare | http://www.lse.ac.uk/Depts/lsehsc/discussionpapers.htm |
| Gregory G. Kelly - Improving the PPI Sample for Prescription Pharmaceuticals - December 1999 - (26 pages) | http://www.brook.edu/dybdocroot/es/research/projects/productivity/workshops/19991217_01.pdf |
| AUTM - Association of University Technology Managers, Inc.- Licensing Survey: FY 1999 Survey Summary | http://www.autm.net/surveys/99/survey99A.pdf |
| Cornell University list of Supreme Court decisions | http://supct.law.cornell.edu/supct/topiclist.html |
| Azizkhon Jafarov - Selection of essential drug lists in Central Asian Republics. Comparison and discrepancies - May 2002 | http://dcc2.bumc.bu.edu/richardl/RPM+_Project/Aziz.htm |
| Sean Nicholson Patricia M. Danzon Jeffrey McCullough - Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality - January 2002 - (46 pages) | http://hc.wharton.upenn.edu/danzon/PDF%20Files/biodeals.pdf |
| Patricia M. Danzon - Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents - (23 pages) | http://hc.wharton.upenn.edu/danzon/PDF%20Files/commissionfinal12.15.01.pdf |
| Patricia M. Danzon - Making Sense of Drug Prices - Regulation Volume 23, No. 1 - (8 pages) | http://hc.wharton.upenn.edu/danzon/PDF%20Files/SenseDruPri2000.pdf |
| Patricia M. Danzon, Li-Wei Chao - Cross-national price differences for pharmaceuticals: how large, and why? - Journal of Health Economics 19 2000 159–195 - (37 pages) | http://hc.wharton.upenn.edu/danzon/PDF%20Files/CrossNational2000.pdf |
| Patricia M. Danzon - Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU." International J. of the Economics of Business." 4(3) 1997 | http://hc.wharton.upenn.edu/danzon/PDF%20Files/Welfare_Effects_1997.pdf |
| Patricia M. Danzon - The Pharmaceutical Industry - (37 pages) | http://hc.wharton.upenn.edu/danzon/PDF%20Files/5880book.pdf |
| Richard T. Rapp & Adam Lloyd - "Civilized" Pharmaceutical Price Regulations: Can The U.S. Have It Too? - The Cato Review of Business & Government | http://www.cato.org/pubs/regulation/regv17n2/reg17n2-rapp.html |
| Catalin Cosovanu - Intellectual Property and Technological Development in Central and Eastern Europe - Stanford University - May 2001 - (104 pages) | http://www.stanford.edu/~cosovanu/diverse/Thesis.pdf |
| Robert P. Merges * and Richard R. Nelson - On the Complex Economics of Patent Scope - 90 Colum. L. Rev. 839 - (62 pages) | http://cyber.law.harvard.edu/ipcoop/90merg2.html |
| Carlos M. Correa - Recent Developments in the Field of Pharmaceutical Patents: Implementation of the TRIPs Agreement - December 1998 | http://www.haiweb.org/campaign/novseminar/correa2.html |
| Jacqueline D. Wright - Implications of Recent Patent Law Changes on Biotechnology Research and the Biotechnology Industry . Virginia Journal of Law and Technology Spring 1997 | http://vjolt.student.virginia.edu/text_only/vol1/vol1_art2.html |
| Penn University - Confidential Financial Disclosure Statement | http://www.upenn.edu/researchservices/pdfs/findisc.pdf |
| F. M. Scherer - The Pharmaceutical Industry and World Intellectual Property Standards - Vanderbilt Law Review Vol. 53:6:2245 - (10 pages) | http://law.vanderbilt.edu/lawreview/vol536/scherer.pdf |
| Peter Drahos and John Braithwaite - The Globalisation of Regulation - (26 pages) | http://www.oiprc.ox.ac.uk/EJWP0200.pdf |
| Peter Drahos - The Universality of Intellectual Property Rights - Origins and Development - (36 pages) | http://www.wipo.org/globalissues/events/1998/humanrights/papers/pdf/drahos.pdf |
| Joshua T. Cohen Keith Duggar George M. Gray Silvia Kreindel - Evaluation of the Potential for Bovine Spongiform Encephalopathy in the United States - Harvard Center for Risk Analysis Harvard School of Public Health - (127 pages) | http://www.aphis.usda.gov/oa/bse/mainreporttext.pdf http://www.fda.gov/oc/bse/harvard_study.html |
| Dina Mirpuri - Ethical and Management Considerations of Conducting International Clinical Trials in Developing Countries - Boston University School of Public Health - (25 pages) | http://dcc2.bumc.bu.edu/richardl/IH820/Resource_materials/Dina-CRO-Dev_countries-051102.doc |
| MIT - POPI Working Abstracts | http://web.mit.edu/popi/abstract3.html#wp60 |
| Robert J. Blendon et al. - Inequities In Health Care: A Five-Country Survey Access-to-care experiences across the five countries tend to vary along with the countries’ insurance coverage policies - (10 pages) | http://www.healthaffairs.org/freecontent/v21n3/s22.pdf |
| Institut de droit de la santé (IDS) Tribunal fédéral suisse Jurisprudence 1974 - 1984 en matière de droit de la santé | http://www.unine.ch/ids/TF/fran7484.htm |
| Institut de droit de la santé (IDS) Tribunal fédéral suisse Jurisprudence 1985 - 1995 en matière de droit de la santé | http://www.unine.ch/ids/TF/tf.htm |
| Timothy S. Lesar - Medication Prescribing Error Reporting and Prevention Program: A 14-Year Experience - Medscape Pharmacists 1(2), 2000. © 2000 Medscape | http://www.medscape.com/viewarticle/408567_print |
| Leonard Davis Institute of Health Economics (and LDI Issue Brief on sale of Prescription Drugs Over the Internet) | http://www.upenn.edu/ldi/ http://www.upenn.edu/ldi/issuebrief5_3.pdf |
| James Gregory Cullem - Panning for Bioetchnology Gold Reach-Through Royalty Damage Awards for Infringing Uses of Patented Molecular Sieves- 39 J.L. & TECH. 553 - (17 pages) | http://www.idea.piercelaw.edu/articles/39/39_4/17.Cullem.pdf |
| Phanesh Koneru - To Promote the Progress of Useful Articles? An Analysis of the Current Utility Standards of Pharmaceutical Products and Biotechnology Research Tools - 38 IDEA 625 - (64 pages) | http://www.idea.piercelaw.edu/articles/38/38_4/20.Koneru.pdf |
| Dan L. Burk and Mark A. Lemley - Is Patent Law Technology-Specific? - Draft - (3 pages) | http://arxiv.org/ftp/cs/papers/0109/0109107.pdf |
| Boston University Journal of Science & Technology Law Symposium - Probing the Human Genome: Who Owns Genetic Information? - 4 B.U. J. SCI. & TECH. L. 2 - February 1997 - (43 pages) | http://www.bu.edu/law/scitech/volume4/4jstl02.pdf |
| Taeku Lee and J. Eric Oliver - Public Opinion and the Politics of America's Obesity Epidemic -John F. Kennedy School of Government Harvard University Faculty Research Working Papers Series - May 2002 - (40 pages) | http://ksgnotes1.harvard.edu/Research/wpaper.nsf/rwp/RWP02-017/$File/rwp02_017_lee.pdf |
| Ronald F. White and Sean Fraley - Imperfect Competion, Price-Fairness, and the Pharmaceutical Industry | http://www.stthom.edu/cbes/oje/articles/white.html |
| Joseph A. DiMasi - Price Trends for Prescription Pharmaceuticals 1995-1999 - Tufts Center for the Study of Drug Development -- August 2000 | http://aspe.hhs.gov/health/reports/Drug-papers/dimassi/dimasi-final.htm |
| Beth Cunningham , Gary Gaffield, Andrea Halpern, Jerome Rackoff - Starting an Institutional Review Board at a PUI - (12 pages) | http://www.facstaff.bucknell.edu/cunningm/%5Cpromotion%5CIRB.article.CURQFinal.pdf |
| AAU - Task Force on Research Accountability - Report and Recommendations - Report on Individual and Institutional Financial Conflict of Interest - October 2001 - (22 pages) | http://www.aau.edu/research/COI.01.pdf |
| Stem Cell Research: A Target Article Collection - (28 pages) | http://muse.jhu.edu/demo/ajb/2.1green.pdf |
| Glenn McGee, Joshua P. Spanogle, Arthur L. Caplan, David A. Asch- A National Study of Ethics Committees | http://bioethics.net/ethicsstudy/AJOB_ethics.pdf http://bioethics.net/ethicsstudy/CQHE_ethics.pdf |
| Peter A Singer, Edmund D Pellegrino and Mark Siegler - Debate Clinical ethics revisited - BMC Medical Ethics (2001) 2:1- (8 pages) | http://www.biomedcentral.com/content/pdf/1472-6939-2-1.pdf |
| Judy E. Stern and Deni Elliott- The Ethics of Scientific Research A Guidebook for course development - (75 pages) | http://www.dartmouth.edu/artsci/ethics-inst/Stern_Elliott.pdf |
| Solomon R Benatar, Peter A Singer - A new look at international research ethics - (3 pages) | http://www.md.ucl.ac.be/ebim/research.pdf |
| Lois Snyder and Daniel P. Sulmasy - Physician-Assisted Suicide - (8 pages) | http://www.annals.org/issues/v135n3/pdf/200108070-00015.pdf |
| Lori B. Andrews - Conceptual Framework for Genetic Policy: Comparing the Medical, Public Health and Fundamental Rights Models - Wust - (65 pages) | http://law.wustl.edu/WULQ/79-1/791-221.pdf |
| Ethics, Genetic Technologies, and Social Responsibility in the Twenty-first Century - (40 pages) | http://bancroft.berkeley.edu/ROHO/bioethics.pdf |
| Darden - University of Virginia - Genzyme/Geltex pharmaceuticals joint venture- - (do not copy status) - (15 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID200849_code991214200.pdf?abstractid=200849 |
| Sara
F. Ellison & Christopher M. Snyder - COUNTERVAILING POWER IN
WHOLESALE PHARMACEUTICALS MIT - Department of Economics - Working Paper 01-27 - July 2001 - (40 pages) |
http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID277290_code010725500.pdf?abstractid=277290 |
| David W. Ramey, Mahlon Wagner, Robert H. Imrie, Victor Stenger, Homeopathy and Science: A Closer Look, | http://www.phys.hawaii.edu/vjs/www/med/homeop.htm |
| Committee on Transgenic Nomenclature, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Standardized Nomenclature for Transgenic Animals, ILAR News Vol 34(4) -- 1992 | http://www4.nas.edu/cls/ijhome.nsf/44bf87db309563 |
| Ashish Arora, Alfonso Gambardella,Fabio Pammolli, Massimo Riccaboni, The Nature and the Extent of the Market for Technology in Biopharmaceuticals, EPRIS, - December 2000 - (42 pages) | http://www.unisi.it/epris/abstract/biotec.doc |
| Harvey E. Bale, Consumption and trade in off- patented medicines. ICRIER, Working Paper n° 65 - May, 2001 - (29 pages) | http://www.icrier.res.in/pdf/bale65.PDF |
| John Barton, Differentiated pricing of patented products, ICRIER Working Paper n° 63 - March, 2001 - (27 pages) | http://www.icrier.res.in/pdf/barton63.PDF |
| Edward M. Basile, Ellen Armentrout & Kelly N. Reeves, Medical Device Labeling and Advertising: An Overview, 54 Food and Drug Law Journal 519-534 (1999) - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art2.pdf |
| J. Howard Beales III, Modification and Consumer Information: Modern Biotechnology and the Regulation of Information, 55 Food and Drug Law Journal 105-118 (2000) - (14 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art6.pdf |
| Eric M. Blumberg, Abbott Laboratories Consent Decree and Individual Responsibility Under the Federal Food, Drug, and Cosmetic Act, 55 Food and Drug Law Journal 145-150 (2000) - (6 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art9.pdf |
| Robert A. Book, Public Research Funding and Private Innovation: The Case of the Pharmaceutical Industry, December 2000 - (72 pages) | http://home.uchicago.edu/~rabook/Book_PharmInnov.pdf |
| Maureen McKelvey* and Luigi Orsenigo - Pharmaceuticals as a Sectoral Innovation System - November 2001 - (74 pages) | http://www.cespri.uni-bocconi.it/essy/mckelors.PDF |
| Alan Sager, Deborah Socolar, Cutting Prescription Drug Spending by Paying Federal Supply Schedule Prices - Boston University - August 2000 - (49 pages) | http://dcc2.bumc.bu.edu/hs/sager/Cutting%20Rx%20prices%20in%208%20northeast%20states%202%20Aug%2000.pdf |
| Nicola Lacetera and Luigi Orsenigo - Political regimes, technological regimes and innovation in the evolution of the pharmaceutical industry in the USA and in Europe - CEPRIS - March 2001 - (rough draft) - (59 pages) | http://www.unisi.it/ricerca/prog/epris/abstract/pdf/Lacetera-Orsenigo-Baltimore2.PDF |
| CESPRI - Centre for Research on Innovation and Internationalisation - home page | http://www.cespri.uni-bocconi.it/ |
| ERPIS - home page - "The main objective of EPRIS is to develop a comprehensive analysis of the structure and evolution of the European Pharmaceutical Regulation and Innovation Systems" | http://www.unisi.it/ricerca/prog/epris/index.htm |
| Program on the Pharmaceutical Industry - MIT Sloan School of Management - Cambridge, Massachusetts | http://web.mit.edu/popi/ |
| Corey A. Salsberg - Resurrecting the Woolly Mammoth: Science, Law, Ethics, Politics, and Religion - 2000 STAN. TECH. L. REV. 1 - Stanford University - | http://stlr.stanford.edu/STLR/Articles/00_STLR_1/index.htm |
| Gary Edmond and David Mercer - Trashing "Junk Science" - 1998 STAN. TECH. L. REV. 3 - Stanford University | http://stlr.stanford.edu/STLR/Articles/98_STLR_3/index.htm |
| Jennifer Kulynych- Intent to Deceive: Mental State and Scienter in the New Uniform Federal Definition of Scientific Misconduct - 1998 STAN. TECH. L. REV. 2 - Stanford University | http://stlr.stanford.edu/STLR/Articles/98_STLR_2/index.htm |
| John H. Barton - Competition and Competitive Uses of Intellectual Property - Symposium Paper - (do not cite status) - Stanford University | http://stlr.stanford.edu/STLR/Symposia/Antitrust/index.htm |
| Ashish Arora and Andrea Fosfuri - Licensing in the Chemical Industry - Symposium Paper - (Do not cite status) - April 1998 - Stanford University | http://stlr.stanford.edu/STLR/Symposia/Antitrust/index.htm |
| John H. Barton - The Impact of Contemporary Patent Law on Plant Biotechnology Research - Symposium Paper - (Do not cite status) | http://stlr.stanford.edu/STLR/Symposia/Antitrust/index.htm |
| Mark A. Lemley - Ration Ignorance at the Patent Office - Essay - Northwestern University Law Review Vol.95 n° 4 - Working Paper from Berkeley web site- 2001 - (39 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/101.pdf |
| John R. Allison & Mark A. Lemley - The Growing Complexity of the United States Patent System - Working Paper from Berkeley web site - 2001 - (84 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/201.pdf |
| Richard J. Gilbert and Willard K. Tom - Is Innovation King at the Antitrust Agencies?: The Intellectual Property Guidelines Five Years Later - April 2001 - Working paper from Berkeley web site - (47 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/601.pdf |
| Matthew J. Conigliaro, Andrew C. Greenberg & Mark A. Lemley - Foreseeability in patent law - Working paper from Berkeley web site - 2001 - (34 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/701.pdf |
| Erik Bierbauer - Liquid Honesty: The first Amendment Right to Market the Health Benefits of Moderate Alcohol Consumption - Ney York University Law Review - Vol. 74:1057 - (42 pages) | http://www.nyu.edu/pages/lawreview/74/4/bierbauer.pdf |
| David C. Vladeck , Devaluing Truth: Unverified Health Claims in the Aftermath of Pearson v. Shalala, 54 Food and Drug Law Journal at 535 - (20 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art3.pdf |
| Richard F. Kingham and Grant H. Castle - Data and Marketing Exclusivity for Pharmaceuticals in the European Community - 55 Food and Drug Law Journal 209 - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/55_2/art3.pdf |
| Patrice Trouiller, Els Torreele, Piero Olliaro, Nick White, Susan Foster, Dyann Wirth and Bernard Pecoul - Drugs for neglected diseases: a failure of the market and a public health failure? - Tropical Medicine and International Health - November 2001 | http://www.neglecteddiseases.org/tmih.pdf |
| Deepak Somaya & David J. Teece - Combining Patented Inventions in Multi-invention Products: Transactional Challenges and Organizational Choices - Working paper from Berkeley web site - August 2001 - (49 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/801.pdf |
| Janice M. Mueller, The Evoling application fo the written description requirement to biotechnology inventions - Berkeley Technology Law Journal- Issue 13:2 - 1998 | http://www.law.berkeley.edu/journals/btlj/articles/13_2/Mueller/html/reader.html |
| Robert Heidt - Maintaining incentives for bioprospecting: the occasional need for a right to lie - Berkeley Technology Law Journal - issue: 13:2 - 1998 | http://www.law.berkeley.edu/journals/btlj/articles/13_2/Heidt/html/reader.html |
| Lawrence B. Landman - Did Congress Actually Create Innovation Markets? - Berkeley Technology Law Journal - Issue 13:2 - 1998 - | http://www.law.berkeley.edu/journals/btlj/articles/13_2/Landman/html/reader.html |
| Institut de droit de la santé - home page - Faculté de droit et des sciences économiques - Université de Neuchâtel | http://www.unine.ch/ids/ |
| Institut d'économie et management de la santé - home page - "institut interdisciplinaire créé en 1998 à l’Université de Lausanne par l’Ecole des Hautes Etudes Commerciales (HEC) et la Faculté de médecine" | http://www.hospvd.ch/iems/ |
| An Assessment of US Pharmaceutical Donations - Edited by Michael R. Reich - Harvard School of Public Health | http://www.hsph.harvard.edu/faculty/reich/donations/ |
| U.S. Patent Law Research Guide - Specialized Guide n° 2 - George Washington University Law School | http://www.law.gwu.edu/burns/guides/patent.pdf |
| Arti K. Rai & Rebecca S. Eisenberg - The Public and the Private in Biopharmaceutical Research - (20 pages) | http://www.law.duke.edu/pd/papers/raieisen.pdf |
| Arti K. Rai 1 - ADDRESSING THE PATENT GOLD RUSH: THE ROLE OF DEFERENCE TO PTO PATENT DENIALS - DRAFT: Please do not cite or quote - (35 pages) | www.acusd.edu/~arai/washu.pdf |
| Guilio Bottazzi, Giovanni Dosi, Marco Lippi, Fabio Pammolli, Massimo Riccaboni Innovation and Corporate Growth in the Evolution of the Drug Industry, EPRIS, July 2000 | http://www.unisi.it/epris/abstract/pdf/geroski.pdf |
| Leah Brannon, Regulating Drug Promotion on the Internet, 54 Food and Drug Law Journal 599-622 (1999), | http://www.fdli.org/pubs/Journal%20Online/54_4/art8.pdf |
| Stefano Breschi, Francesco Lissoni and Luigi Orsenigo, Success and failure in the development of biotechnology clusters: the case of Lombardy | http://nt-notes.liuc.it/ricerca/IstitutoEconomia.nsf/c6d95ba0f57aa4cac12567b0005a08ba/a13ef9d5ce2843aec1256a14006878de/$FILE/Stuttbook.PDF |
| S. Casper and H. Kettler, National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models: The German and UK Biotechnology Sectors | http://www.unisi.it/epris/abstract/Casper_Kettler.doc |
| John Y. Chai, Medical Device Regulation in the United States and the European Union: A Comparative Study, 55 Food and Drug Law Journal 57-80 (2000), | http://www.fdli.org/pubs/Journal%20Online/55_1/art4.pdf |
| Ian M. Cockburn, Rebecca Henderson and Scott Stern, The Diffusion of Science Driven Drug Discovery: Organizational Change in Pharmaceutical Research, September 1999 | http://www2.cid.harvard.edu/cidbiotech/events/Hend2.pdf |
| Ian Cockburn, Rebecca Henderson and Scott Stern, Balancing Incentives: The Tension Between Basic and Applied Research, August 2000, | http://webuser.bus.umich.edu/departments/busecon/research/papers/BalanceSep00.pdf |
| T.A.B. Corley, The British Pharmaceutical Industry Since 1851 - (33 pages) | http://www.rdg.ac.uk/Econ/Econ/workingpapers/emdp404.pdf |
| Rochelle Cooper Dreyfuss, Collaborative Research: Conflicts on Authorship, Ownership, and Accontability, 53 Vand. L. Rev. 1055-1388 (May 2000) | http://law.vanderbilt.edu/lawreview/vol534/dreyfuss.pdf |
| Manfred Fleischer, Sabine Kelm, Deborah Palm, Regulation and Innovation in the Chemical Industry, L. Delgado (editor), October 2000, Institute for Prospective Technological Studies, | http://www.teesvalley-jsu.gov.uk/dicidauk/keyissues/chemstrat/eur19735en.pdf |
| H.E. Frech III and Richard D. Miller Jr., The Productivity of Health Care and Pharmaceuticals: An International Comparison, December 1996, -do not quote status- (67 pages) | http://www.econ.ucsb.edu/papers/health.pdf |
| Jeffrey L. Furman, Firm effects vs. Location effects in the organization of pharmaceutical research, January 2001, | http://web.mit.edu/jfurman/www/firm%20v%20industry%20effects%20-%20draft%20Jan01.pdf |
| Alfonso Gambardella, Luigi Orsenigo, Fabio Pammolli, Global Competitiveness in Pharmaceuticals, A European Perspective, , November 2000, report prepared for the Directorate General Enterprise of the European Commission, | http://www.unisi.it/epris/abstract/pdf/pharma.pdf |
| Rebecca Henderson, Luigi Orsenigo, Gary P. Pisano, The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions between Scientific, Institutional and Organizational Change, April 1998, | http://www2.cid.harvard.edu/cidbiotech/events/Hend1.pdf |
| Cass R. Sunstein - Social and Economic Rights? Lessons from South Africa ? - Working Paper - n° 12 - (page 17) | http://www.law.uchicago.edu/academics/publiclaw/resources/12.CRS.pdf |
| Kym Anderson, Chantal Pohl Nielsen and Sherman Robinson - Estimating the Economic Effects of GMOs: the Importance of Policy Choices and Preferences - Policy Discussion Paper No. 0035 -August 2000- Adelaide University - Australia - (40 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID243553_code000925130.pdf?abstractid=243553 |
| Lucas Bergkamp - Allocating Unknown Risk : Liability for Environmental Damages Caused by Deliberately Released Genetically Modified Organisms - Brussels - 2000 - (32 pages) | http://papers.ssrn.com/sol3/delivery.cfm/000411502.pdf?abstractid=223068 |
| Chantal Nielsen and Kym Anderson - GMOs, Trade Policy, and Welfare in Rich and Poor Countries - May 2000 - (43 pages) - Policy Discussion Paper No. 0021 - University of Adelaide - Australia | http://papers.ssrn.com/sol3/delivery.cfm/000602350.pdf?abstractid=231201 |
| Chantal Nielsen and Kym Anderson - Global Market Effects of Alternative European Responses to GMOs - Policy Discussion Paper No. 0032 - University of Adelaide - Australia - (24 pages) | http://papers.ssrn.com/sol3/delivery.cfm/000816360.pdf?abstractid=239451 |
| Social Science Research Network - SSRN - home page - "devoted to the rapid worldwide dissemination of social science research" | http://www.ssrn.com/ |
| William W. Fisher III - Professor of Law, Harvard University Harvard- bioprospecting - Works in Progress - in Legal Reform in Central America (forthcoming, Harvard University Press, 2000) | http://www.law.harvard.edu/Academic_Affairs/coursepages/tfisher/bioprospecting.html |
| William W. Fisher III - The Growth of Intellectual Property: A History of the Ownership of Ideas in the United States - Harvard University - Eigentum im internationalen Vergleich (Vandenhoeck & Ruprecht, 1999), 265-91 | http://www.law.harvard.edu/Academic_Affairs/coursepages/tfisher/iphistory.html |
| William W. Fisher III - The Impact of “Terminator Gene” Technologies on Developing Countries - Report to the UK Department for International Development, December 1999 - Harvard University | http://www.law.harvard.edu/Academic_Affairs/coursepages/tfisher/terminator.html |
| Dror
Ben-Asher - In Need of Treatment ? Merger Control, Pharmaceutical
Innovationn & Consumer Welfare - Discussion Paper No. 270 12/99 - Harvard Law School - (110 pages) |
http://www.law.harvard.edu/programs/olin_center/papers/pdf/270.pdf |
| Research Reports of ETH Zurich and the University of Zurich | http://www.rereth.ethz.ch/cgi-bin/TreeControlCGI_rereth?ds=rereth_en&ri=en&sr=1 |
| The Committee For the Protection of Human Subjects - homepage - University of California at Berkeley | http://cphs.berkeley.edu:7006/ |
| Jeffrey M. Perloff, Valerie Y. Suslow, and Paul J. Seguin - Higher Prices from Entry: Pricing of Brand-Name Drugs - Working Paper No. CPC99-03 - University of California at Berkeley - (39 pages) | http://www.haas.berkeley.edu/groups/cpc/WPs/99-3_are778.pdf |
| Robert P. Merges - Institutions for Intellectual Property Transactions: The Case of Patent Pools August - 1999 Revision - (74 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/merges/pools.pdf |
| Robert P. Merges -As Many as Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and Patent System Reform - University of California at Berkeley - (39 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/merges/siximp.pdf |
| Robert P. Merges - Property Rights Theory and the Commons: The Case of Scientific Research - 1996- Cambridge - (24 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/merges/rpmart4.pdf |
| Science, Technology, and Society Studies .- STS - home page - "interdisciplinary field combin[ing] sociological, historical, anthropological, economical and ethnographical approaches to understanding science, technology and society" | http://www.sts.unige.ch/ |
| Bibliography (list) on the History and Philosophy of the Life Sciences, especially Molecular Biology and Medicine - collected by Bruno J Strasser | http://www.medecine.unige.ch/~strasser/biblio.htm |
| Institut Louis Jeantet d'Histoire de la Médecine - Institut Romand d'histoire de la médecine et de la Santé - Centre collaborateur OMS pour la recherche historique en santé publique | http://www.medecine.unige.ch/newfacmed/jeantet.html |
| Tomas Poledna - Medikamentenabgabe durch Ärzte (Selbstdispensation) - Jusletter - January 14, 2001 | http://pdf.weblaw.ch/pdf.asp?ArticleNr=1456&LanguageNr=1 |
| Gianfranco Domenighetti & Luca Crivelli - SECURITE DE L'APPROVISIONNEMENT EN MEDECINE DE VILLE DANS LE CADRE DE LA SUPPRESSION DE L’OBLIGATION DE CONTRACTER -August 2001 - (47 pages) | http://www.santesuisse.ch/datasheets/files/20020211111931.PDF |
| Michael Abramowicz - Perfecting Patent Prizes - (126 pages) | http://www.gmu.edu/departments/law/faculty/papers/docs/01-29.pdf |
| Michal Cohen - Patent Protection of Biotechnological Inventions – Economic Perspectives and the EC Directive Analysis - August 2001 - (63 pages) | http://www.frg.eur.nl/rile/emle/Theses/cohen.pdf |
| Amicus curiae before the Supreme Court from the Consumer Project on Technology on Festo Corporation, Petitioner, v. Shoketsu Kinzoku Kogyo Kabushiki Co., LTD., a/k/a SMO Corp. and SMC Pneumatics, Inc., Respondents. - (41 pages) | http://supreme.usatoday.findlaw.com/supreme_court/briefs/00-1543/00-1543.mer.ami.cpt.pdf |
| Arti K. Rai - THE INFORMATION REVOLUTION REACHES PHARMACEUTICALS: BALANCING INNOVATION INCENTIVES, COST, AND ACCESS IN THE POST-GENOMICS ERA - Draft - Do not Cite or Quote - (44 pages) | http://www.utexas.edu/law/news/colloquium/papers/Raipaper.doc |
| John Goldsmith - The Exogenous Regulator: Explaining Variation in Time to Approve Generic Drugs - November 2000 - DRAFT Please do not cite or disseminate without permission - (62 pages) | http://www.cramton.umd.edu/workshop/papers/goldsmith-the-exogenous-regulator.pdf |
| F. Scott Kieff - Facilitating Scientific Research : Intellectual Property Rights and the Norms of Science – A Response to Rai and Eisenberg - 95 NW. U. L. REV. - (18 pages) | http://www.law.nwu.edu/faculty/visiting/kieff/propertyandnorms.pdf |
| GERALD J. MOSSINGHOFF - Overview of the Hatch-Waxman Act and Its Impact on the Drug Development Process - 54 Food and Drug Law Journal 187 (1999) | http://www.fdli.org/pubs/Journal%20Online/54_2/art2.pdf |
| Suresh Koshy - The Effect of TRIPs on Indian Patent Law: A Pharmaceutical Industry Perspective - 1 B.U. J. SCI. & TECH. L. 4. - (27 pages) | http://www.bu.edu/law/scitech/volume1/KOSHY.PDF |
| Jean O. Lanjouw - A Patent Policy Proposal for Global Diseases - Yale University, the Brookings Institution and the NBER - April 2001 - (40 pages) | http://econ.worldbank.org/files/1733_lanjouw.pdf |
| Rebecca S. Eisenberg - Analyze This: A Law & Economics Agenda for the Patent System - VANDERBILT LAW REVIEW [Vol. 53:6:2081 - 2000 - (18 pages) | http://law.vanderbilt.edu/lawreview/vol536/eisenberg.pdf |
| J.H. Reichman and David Lange - Bargaining around the trips Agreement: the case for ongoing Public-private initiatives to Facilitate worldwide intellectual Property transactions - DUKE JOURNAL OF COMPARATIVE & INTERNATIONAL LAW [Vol 9:11 -(58 pages) | http://www.law.duke.edu/journals/djcil/downloads/djcil9p11.pdf |
| John R. Thomas - HIV/AIDS Drugs, Patents and the TRIPS Agreement: Issues and Options - July 27, 2001 - Congressional Research Service The Library of Congress - (27 pages) | http://rxpolicy.com/studies/crs-aidspatentstrips-0701.pdf |
| Frederick M. Abbott - The TRIPS Agreement, Access to Medicines and the WTO Doha Ministerial Conference - September 8, 2001 - (42 pages) | http://hostings.diplomacy.edu/quaker/new/doc/OP7%20Abbott1.pdf |
| Frederick
M. Abbott - Compulsory Licensing for Public Health Needs: The TRIPS
Agenda at the WTO after the Doha Declaration on Public Health - Occasional Paper 9 -Quaker United Nations Office – Geneva - February 2002 - (58 pages) |
http://www.cptech.org/ip/health/cl/quno-op9.pdf |
| Research Practicioner Journal, home page | http://www.researchpractice.com/ |
| Several articles on the history of FDA - Food and Drug Law Journal 50th anniversary Special Issue - 1995 | http://www.fdli.org/pubs/Journal%20Online/jour_toc/vol50_Special.html |
| Sheila R. Shulman and Jeffrey S. Brown - The Food and Drug Administration’s Early Access and Fast-Track Approval Initiatives: How Have They Worked? - 50 Food and Drug Law Journal 385-388 (1995) - (29 pages) | http://www.fdli.org/pubs/Journal%20Online/50_4/art4.pdf |
| William Green - Consumer-Directed Advertising of Contraceptive Drugs: The FDA, Depo-Provera, and Product Liability - 50 Food and Drug Law Journal 553-567 (1995) - (15 pages) | http://www.fdli.org/pubs/Journal%20Online/50_4/art6.pdf |
| Amir Attaran - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Options for TRIPS Council - Working draft - (12 pages) | http://www2.cid.harvard.edu/cidwp/087.pdf |
Restricted area
+ A list of authors from academic institutions
+ A list of Swiss individuals involved in pharmaceuticals' regulations
Last updated: July 8, 2002